Consumers Want Government to Limit Rx Prices

By George Anderson
A telephone poll of 1,200 adults conducted by the nonprofit health research organization, The Kaiser Family Foundation, found that nearly two out of every three questioned believe
the federal government should be more involved in keeping down the prices of prescription medicines.
Less than half, 46 percent, said they would support further government regulation of pricing even if it meant pharmaceutical companies had to reduce their research and development
activities.
Half of those surveyed said they take one or more prescription drugs on a daily basis.
Moderator’s Comment: Should drug retailers support greater government involvement in limiting the prices charged for prescription medicines? Why or why
not?
A report by Reuters pointed out the federal Medicare program is prohibited by law from negotiating prices with drug makers even though other agencies
within the government are allowed. –
George Anderson – Moderator
Join the Discussion!
8 Comments on "Consumers Want Government to Limit Rx Prices"
You must be logged in to post a comment.
You must be logged in to post a comment.
At some point, the voters of this country are going to have to decide whether they consider health care a right or a good. There are a variety of models along that continuum, but we haven’t even made up our minds yet about how to approach the debate. We get surveys like this that show a strong desire for more government involvement, but health care plans that allow for government regulated health care provisions are shot down as “socialized medicine.”
I think there are a lot of tactics for increasing competition and loosening markets that should be tried before we slap another Band-Aid on a broken system.
It seems to me that one indicator of a desperate situation is to look for the arbiter of last resort (the government) to fix things. And, as medical costs eat up more and more of personal income, this is becoming a desperate situation.
Of course, we should want drug companies to continue to invest in finding new solutions and we need them to be able to recover the cost of their discovery and also profit from it. We just do not want everyone to profit too much.
My opinion is that we all should support more scrutiny and review. Certainly from ourselves, but also from the government.
While I understand – and generally share – a natural reticence to have too much of life controlled by government, there comes a time when regulations are needed because voluntary behaviour is out of order. With no ceiling on the prices that can be charged for drugs, there is little or no reason for manufacturers to consider what customers can and can’t afford. Assuming that all medications prescribed by doctors are actually essential to patients’ health, the term “needs must” has to apply. People don’t actually have the choice about whether or not to make a purchase. Nor is it reasonable for manufacturers to assume that what individuals can’t afford will be underwritten by insurance companies (who will, of course, ensure that they get their money back from individuals come hell or high water through increased premiums and penalties). Under those circumstances, it is incumbent on manufacturers and retailers to price things reasonably. As this isn’t always the case, though, some external force needs to be brought to bear.
I prefer the solution so ably outlined by David Livingston, which allows the marketplace to dictate prices rather than the government. Currently there are so many impediments to wide-open commerce in prescriptions that the U.S. pharmaceutical industry essentially operates a monopoly.
Open up your history books and look back about 30 years or so. At that time, a guy tried that (price controls, that is) and it was a miserable failure. It would also be a miserable failure now and itt would add more corruption to an already corrupted industry – if that is possible.